[{"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-001", "question": "An 82-year-old woman with mild cognitive impairment presents with recurrent falls and orthostatic hypotension. She takes donepezil 10 mg daily. Autonomic testing shows sympathetic denervation. Brain MRI reveals hippocampal atrophy. What is the most likely underlying diagnosis contributing to her symptoms?", "options": ["Alzheimer disease with autonomic involvement", "Lewy body dementia", "Multiple system atrophy", "Vascular parkinsonism", "Progressive supranuclear palsy"], "answer": "B", "answer_index": 1, "explanation": "Lewy body dementia often presents with orthostatic hypotension due to autonomic dysfunction, recurrent falls, and cognitive impairment with hippocampal atrophy on MRI. Alzheimer disease rarely causes significant autonomic symptoms, while multiple system atrophy typically has more severe parkinsonism and cerebellar signs. Vascular parkinsonism and PSP lack prominent autonomic features.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "abms_specialty": "Geriatrics", "abms_source": "target_topic", "source_label_raw": "Geriatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "B", "model_outputs": "This patient presents with mild cognitive impairment (MCI), recurrent falls, and orthostatic hypotension. The key to answering this question lies in interpreting the autonomic testing and MRI findings to distinguish between the neurodegenerative etiologies.\n\n1.  Clinical Picture: The combination of cognitive impairment and prominent autonomic dysfunction (falls, orthostatic hypotension) is characteristic of synucleinopathies (Lewy body dementia, Parkinson's disease, and Multiple System Atrophy).\n2.  Autonomic Testing: The finding of sympathetic denervation is a crucial discriminator.\n    *   Lewy Body Disorders (DLB, Parkinson's disease) and Pure Autonomic Failure are associated with postganglionic sympathetic denervation. In these conditions, there is a loss of catecholaminergic neurons in the peripheral sympathetic nervous system (including the heart). This is often visualized clinically using MIBG myocardial scintigraphy, which shows reduced uptake.\n    *   Multiple System Atrophy (MSA) is associated with preganglionic failure; the postganglionic sympathetic neurons are generally intact. Consequently, evidence of peripheral sympathetic denervation argues strongly against MSA.\n    *   Alzheimer Disease (AD) typically does not present with significant dysautonomia or sympathetic denervation.\n3.  MRI Findings: The patient has hippocampal atrophy. While this is the hallmark of AD, it is frequently present in elderly patients with Lewy body dementia (DLB), especially those with mixed pathology (amyloid/tau + Lewy bodies) or those in advanced age. Crucially, the preservation of the hippocampus is used to support DLB over AD, but the *presence* of atrophy does not rule out DLB, whereas the presence of sympathetic denervation effectively rules out AD and MSA in the context of this specific autonomic differentiation.\n4.  Conclusion: Lewy body dementia (DLB) explains the MCI (prodromal DLB), the recurrent falls, the orthostatic hypotension, and specifically the sympathetic denervation. AD does not explain the sympathetic denervation. MSA is excluded by the finding of frank sympathetic denervation (as opposed to preganglionic failure).\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-002", "question": "A 6-month-old infant with known tetralogy of Fallot develops sudden cyanosis and agitation during a routine clinic visit. The child is tachypneic with oxygen saturation of 65%. Echocardiography shows severe right ventricular outflow tract obstruction. After initial stabilization with knee-to-chest positioning and morphine, what is the next best pharmacologic intervention to abort the hypercyanotic spell?", "options": ["Intravenous propranolol", "Subcutaneous epinephrine", "Intravenous phenylephrine", "Oral sildenafil", "Intravenous esmolol"], "answer": "C", "answer_index": 2, "explanation": "Phenylephrine increases systemic vascular resistance, reducing right-to-left shunting in tetralogy of Fallot during a hypercyanotic spell. Propranolol or esmolol may be used but are not first-line for acute spells; epinephrine could worsen infundibular spasm. Sildenafil is not indicated acutely for this scenario.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "C", "model_outputs": "This patient is experiencing a hypercyanotic spell (\"Tet spell\"). The pathophysiology involves increased dynamic right ventricular outflow tract (RVOT) obstruction and decreased systemic vascular resistance (SVR), leading to a significant right-to-left shunt across the ventricular septal defect (VSD).\n\nThe management of a Tet spell proceeds in a stepwise fashion:\n1.  Knee-to-chest positioning: This increases SVR by kinking the femoral arteries, thereby increasing left ventricular pressure and reducing the right-to-left shunt.\n2.  Oxygen: Systemic vasodilator and pulmonary vasodilator, though of limited utility in shunt lesions, it is standard.\n3.  Morphine: Used to decrease agitation and sympathetic drive (catecholamines), which helps reduce RVOT spasm and oxygen demand.\n4.  Intravenous Fluids: To increase preload and stretch the RVOT, reducing dynamic obstruction.\n5.  Vasopressors (Phenylephrine): If the modifications above do not resolve the spell, the goal is to pharmacologically increase SVR to reverse the shunt. Intravenous phenylephrine, a pure alpha-adrenergic agonist, is the drug of choice to acutely increase SVR without increasing cardiac contractility (which would worsen the obstruction).\n6.  Beta-blockers (Propranolol or Esmolol): These can be used to reduce heart rate and contractility, thereby relaxing the infundibular spasm. However, in the acute setting with severe hypoxia, increasing SVR with phenylephrine is often the most rapid and effective hemodynamic intervention to force blood into the pulmonary circulation. Additionally, the presence of two beta-blocker options (Propranolol and Esmolol) typically points towards the alternative effective mechanism (Phenylephrine) in multiple-choice questions. Subcutaneous epinephrine (Option B) is contraindicated as its beta-adrenergic, positive inotropic effects can worsen the RVOT obstruction.\n\nGiven that the patient has already received knee-to-chest positioning and morphine but remains hypoxic, increasing SVR pharmacologically is the physiological priority.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-003", "question": "A 35-year-old woman in the emergency department collapses after ingesting an unknown substance. She has bradycardia, hypotension, and miosis. Atropine provides partial response, but symptoms recur. What is the definitive antidote?", "options": ["Pralidoxime for organophosphate poisoning", "N-acetylcysteine for acetaminophen", "Flumazenil for benzodiazepine overdose", "Physostigmine for anticholinergic toxicity", "Hydroxocobalamin for cyanide"], "answer": "A", "answer_index": 0, "explanation": "This cholinergic toxidrome suggests organophosphate poisoning, where pralidoxime regenerates acetylcholinesterase after initial atropine. Atropine alone is insufficient for severe cases. Other antidotes target different mechanisms not fitting the presentation.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "source_question_id": "20251201T041413890Z_grok-4-0709_seed125-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed125.jsonl", "pred": "A", "model_outputs": "The patient's presentation of bradycardia, hypotension, and miosis (constricted pupils) is classic for a cholinergic toxidrome, specifically organophosphate poisoning. Organophosphates irreversibly inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine at muscarinic and nicotinic receptors.\n\nThe clinical findings associated with muscarinic overstimulation are summarized by the mnemonics DUMBELS (Defecation, Urination, Miosis, Bradycardia/Bronchorrhea, Emesis, Lacrimation, Salivation) or SLUDGE.\n\nAtropine is a muscarinic antagonist used to treat life-threatening symptoms like bradycardia and bronchorrhea. However, it does not bind to nicotinic receptors (which cause muscle weakness/paralysis) and does not regenerate the inhibited acetylcholinesterase enzyme.\n\nPralidoxime (2-PAM) is the definitive antidote that works by reactivating acetylcholinesterase (removing the phosphate group added by the organophosphate), provided it is administered before the enzyme \"ages.\" It helps reverse both muscarinic and nicotinic effects.\n\nLet's review the other options:\n*   N-acetylcysteine is the antidote for acetaminophen (paracetamol) toxicity.\n*   Flumazenil is the antidote for benzodiazepine overdose.\n*   Physostigmine is an acetylcholinesterase inhibitor used for anticholinergic toxicity (e.g., atropine overdose). Giving this to a patient with organophosphate poisoning (who already has inhibited enzyme and excess acetylcholine) would worsen the condition.\n*   Hydroxocobalamin is an antidote for cyanide poisoning.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-004", "question": "A 35-year-old woman at 20 weeks gestation with twin pregnancy develops acute shortness of breath and hemoptysis. Echocardiography shows severe mitral stenosis with pulmonary hypertension. She is hemodynamically stable. What is the most appropriate management?", "options": ["Percutaneous mitral balloon valvuloplasty", "Open mitral commissurotomy", "Therapeutic anticoagulation with heparin", "Beta-blocker therapy for rate control", "Termination of pregnancy"], "answer": "A", "answer_index": 0, "explanation": "Percutaneous valvuloplasty is preferred for severe mitral stenosis in pregnancy as it avoids cardiopulmonary bypass risks to the fetus. Open surgery is higher risk; anticoagulation prevents clots but not stenosis. Beta-blockers manage symptoms but do not address the valve. Termination is not indicated if treatable.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "target_topic", "source_label_raw": "Obstetrics and Gynecology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-015", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "D", "model_outputs": "This patient presents with symptomatic severe mitral stenosis (MS) during the second trimester of a twin pregnancy. The physiological changes of pregnancy (increased plasma volume and heart rate) increase the transmitral gradient, leading to left atrial hypertension. This has resulted in pulmonary hypertension and pulmonary congestion, manifested as shortness of breath and hemoptysis (likely due to rupture of bronchial veins, known as pulmonary apoplexy).\n\nThe management of mitral stenosis in pregnancy follows a stepwise approach based on guidelines (e.g., ACC/AHA, ESC):\n1.  Medical Therapy: The first-line management for symptomatic MS in pregnancy is medical therapy to reduce the heart rate and left atrial pressure. Beta-blockers (Option D) are the mainstay of treatment as they prolong diastole, allowing more time for left ventricular filling and reducing the transmitral gradient. Bed rest and salt restriction are also advised.\n2.  Intervention (PMBV): Percutaneous mitral balloon valvuloplasty (Option A) is indicated for patients with severe MS who have NYHA class III or IV symptoms, or severe pulmonary hypertension, refractory to medical therapy.\n\nSince the patient is described as hemodynamically stable, she should receive a trial of optimal medical therapy (beta-blockers) before considering invasive procedures. PMBV carries procedural risks (e.g., radiation exposure, tamponade, severe mitral regurgitation) and is reserved for cases where medical management fails to control symptoms. Therapeutic anticoagulation (Option C) is indicated for atrial fibrillation or thrombus, which are not mentioned; moreover, anticoagulation could worsen hemoptysis caused by bronchial vein rupture. Termination of pregnancy (Option E) is a last resort for life-threatening intractable heart failure. Open surgery (Option B) poses high risk to the fetus and is reserved for cases where PMBV is not feasible or fails.\n\nTherefore, the most appropriate initial management is beta-blocker therapy.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-005", "question": "A 65-year-old man with aortic stenosis undergoes transcatheter aortic valve replacement under monitored anesthesia care. Intraoperatively, he develops complete heart block. Temporary pacing is initiated, but rhythm does not recover. What is the most appropriate long-term management?", "options": ["Permanent pacemaker implantation", "Observation for 7 days with temporary pacing", "Amiodarone infusion for rhythm control", "Dual-chamber ICD placement", "Surgical valve revision"], "answer": "A", "answer_index": 0, "explanation": "Complete heart block post-TAVR often persists due to conduction system compression, necessitating permanent pacemaker. Observation may be trialed but evidence supports early implantation if persistent. Amiodarone is not for block; ICD is for ventricular arrhythmias. Revision is for valve issues.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-018", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "Based on current clinical guidelines (e.g., 2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement), new-onset complete heart block (CHB) is a well-known complication of TAVR, caused by mechanical compression of the atrioventricular conduction system.\n\nIf CHB develops intraoperatively and persists (\"rhythm does not recover\"), permanent pacing is indicated. While a brief period of observation (typically 24 to 48 hours) is often employed to rule out transient stunning, an observation period of 7 days with a temporary pacing wire is associated with increased risks of infection, perforation, and complications from immobility, and is generally not recommended. Amiodarone would worsen conduction block. An ICD is indicated for ventricular tachyarrhythmias or severe systolic dysfunction, not isolated heart block. Surgical revision is an excessively high-risk intervention for this complication compared to pacemaker implantation.\n\nTherefore, the standard long-term management for persistent complete heart block post-TAVR is the implantation of a permanent pacemaker.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-006", "question": "A 60-year-old woman with bipolar disorder on lithium therapy presents with tremors, confusion, and ataxia. Serum lithium level is 2.5 mmol/L. She has acute kidney injury. What is the most appropriate management to expedite lithium clearance?", "options": ["Hemodialysis", "Forced diuresis with saline", "Gastric lavage", "Activated charcoal administration", "Discontinuation and observation"], "answer": "A", "answer_index": 0, "explanation": "Hemodialysis is indicated for severe lithium toxicity with neurologic symptoms and renal impairment, as it efficiently clears lithium. Diuresis is ineffective with AKI; lavage and charcoal do not bind lithium. Observation risks prolonged toxicity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-020", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step reasoning for the answer:\n\n1.  Assess the Clinical Picture: The patient has lithium toxicity evidenced by a serum level of 2.5 mmol/L and severe neurological symptoms (confusion, ataxia, tremors).\n2.  Identify Complicating Factors: The patient has Acute Kidney Injury (AKI). Since lithium is almost entirely excreted by the kidneys, AKI significantly impairs the body's natural ability to clear the drug.\n3.  Evaluate Indications for Hemodialysis: Standard guidelines (such as those from the EXTRIP workgroup) generally recommend hemodialysis for lithium toxicity in the following scenarios:\n    *   Serum lithium concentration > 4.0–5.0 mEq/L (mmol/L) regardless of symptoms.\n    *   Serum lithium concentration > 2.5 mEq/L (mmol/L) in the presence of severe symptoms (e.g., altered mental status, seizures) or renal impairment/failure.\n4.  Evaluate Other Options:\n    *   Forced diuresis (B) is generally not recommended and is largely considered ineffective or dangerous compared to volume restoration and dialysis. While volume resuscitation with normal saline is appropriate to restore euvolemia, \"forced diuresis\" is not the standard of care for severe toxicity.\n    *   Gastric lavage (C) is generally only considered within 1 hour of an acute ingestion, which does not fit the likely acute-on-chronic presentation involving established therapy and AKI.\n    *   Activated charcoal (D) does not bind to lithium (a heavy metal/ion) and is ineffective.\n    *   Discontinuation and observation (E) is insufficient because the patient has compromised renal function (AKI) and is already symptomatic. Without intervention, lithium levels will likely remain elevated or clear too slowly, leading to potential permanent neurological damage.\n\nConclusion: Given the serum level of 2.5 mmol/L combined with significant neurological symptoms and acute kidney injury, hemodialysis is the most appropriate and effective method to expedite lithium clearance.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-007", "question": "A 50-year-old woman with Crohn's disease presents with an enterocutaneous fistula after ileocolic resection. She is hemodynamically stable but has high-output fistula drainage. Which management strategy is most effective for promoting spontaneous closure?", "options": ["Total parenteral nutrition and somatostatin analog", "Immediate surgical closure with bowel resection", "Antibiotic therapy with abscess drainage", "Hyperbaric oxygen therapy", "Fibrin glue injection into the fistula tract"], "answer": "A", "answer_index": 0, "explanation": "TPN and somatostatin analogs reduce gastrointestinal secretions and promote fistula healing in high-output cases. Surgical closure is reserved for failures, antibiotics address infection not closure, hyperbaric oxygen lacks evidence, and fibrin glue is for low-output fistulas.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step reasoning for the chosen management strategy:\n\n1.  Assessment of the Clinical Picture: The patient has a postoperative enterocutaneous fistula (ECF) following surgery for Crohn's disease. Key features are that she is hemodynamically stable, but the fistula is \"high-output\" (typically defined as >500 mL/24 hours).\n\n2.  General Management Principles (SNAP): The management of ECF generally follows the acronym SNAP:\n    *   Sepsis control (drain abscesses, antibiotics).\n    *   Nutrition (TPN, electrolyte balance).\n    *   Anatomy (imaging to define the fistula).\n    *   Plan (timing of surgery if conservative management fails).\n\n3.  Evaluating Option B (Immediate Surgery): Re-operation in the early postoperative period (between 10 days and 3–6 months) is generally contraindicated due to the \"hostile abdomen.\" Dense vascular adhesions make surgery difficult and increase the risk of creating further bowel injury. Surgery is usually delayed for at least 3–6 months to allowing the inflammation to subside unless there is an acute surgical emergency (e.g., peritonitis), which this stable patient does not have.\n\n4.  Evaluating Option C (Antibiotics/Drainage): While sepsis control is the first priority, the patient is described as hemodynamically stable, implying that uncontrolled sepsis/abscess is not the immediate presenting issue requiring intervention in the prompt. Antibiotics alone do not promote closure of the fistula tract itself.\n\n5.  Evaluating Options D and E: Hyperbaric oxygen and fibrin glue are adjunctive therapies. Fibrin glue has variable success rates and is generally more successful in low-output or long-tract fistulas, not high-output ones.\n\n6.  Evaluating Option A (TPN and Somatostatin Analog):\n    *   Nutrition: High-output fistulas frequently lead to severe malnutrition and fluid/electrolyte imbalance. Malnutrition is a leading cause of failure for spontaneous closure and mortality. Total Parenteral Nutrition (TPN) allows for bowel rest (reducing output) while maintaining nutritional status.\n    *   Somatostatin Analogs (e.g., Octreotide): These define the pharmacological approach to high-output fistulas. They reduce gastrointestinal secretions, thereby decreasing the volume of fistula output. Lower output facilitates wound care and improves the likelihood of spontaneous closure (which occurs in roughly 30-50% of adequately managed cases).\n\n7.  Conclusion: For a stable patient with a high-output fistula, the standard conservative management to promote spontaneous closure involves placing the bowel at rest, correcting nutritional deficits via TPN, and pharmacologically reducing output with somatostatin analogs.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-008", "question": "A 50-year-old woman with migraine presents with hemiplegic episodes and family history of similar symptoms. Genetic testing reveals CACNA1A mutation. What is the most effective prophylactic treatment?", "options": ["Verapamil extended-release", "Topiramate", "Propranolol", "Amitriptyline", "Valproate"], "answer": "A", "answer_index": 0, "explanation": "Verapamil is preferred for familial hemiplegic migraine due to calcium channel involvement. Topiramate and valproate for common migraine, propranolol beta-blockade, amitriptyline for tension overlap.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "target_topic", "source_label_raw": "Neurology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-018", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step reasoning for the answer:\n\n1.  Diagnosis: The patient presents with hemiplegic migraine and a family history of similar episodes, confirming a diagnosis of Familial Hemiplegic Migraine (FHM). The genetic testing identifies a *CACNA1A* mutation, which specifically classifies this as FHM Type 1 (FHM1).\n\n2.  Pathophysiology: *CACNA1A* encodes the pore-forming alpha-1A subunit of the P/Q-type voltage-gated calcium channels. These mutations typically lead to a gain-of-function phenotype, affecting neurotransmitter release.\n\n3.  Treatment mechanism: Because the underlying pathology involves dysfunction of calcium channels, calcium channel blockers are often the preferred prophylactic agents.\n\n4.  Evaluation of Options:\n    *   A. Verapamil extended-release: Verapamil is a calcium channel blocker. Along with flunarizine (another calcium channel blocker not listed) and acetazolamide, verapamil is widely considered a first-line or highly effective prophylactic treatment for FHM1 due to its action on calcium channels.\n    *   B. Topiramate: While effective for general migraine prophylaxis, it is not the specific drug of choice for the underlying mechanism of FHM1 compared to verapamil.\n    *   C. Propranolol: Beta-blockers are standard for common migraine but have historically been avoided or used with caution in hemiplegic migraine due to concerns about prolonged aura or vasoconstriction, though this is debated. They do not target the calcium channel defect.\n    *   D. Amitriptyline: A tricyclic antidepressant used for general migraine prevention, but not specific to the *CACNA1A* channelopathy.\n    *   E. Valproate: Another general migraine prophylactic, but less favored than calcium channel blockers for this specific genetic variant.\n\n5.  Conclusion: Among the choices provided, verapamil is the most mechanistically appropriate and frequently recommended therapy for patients with *CACNA1A* mutations.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-009", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "source_question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed126.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step analysis to determine the best answer:\n\n1.  Diagnosis and Status: The patient has Hypertrophic Cardiomyopathy (HCM) with severe Left Ventricular Outflow Tract (LVOT) obstruction, indicated by a gradient of 80 mmHg (a gradient >50 mmHg is considered the threshold for invasive intervention in symptomatic patients).\n2.  Clinical Course: The patient is symptomatic (exertional syncope) despite medical therapy (beta-blockers). This defines the condition as drug-refractory symptomatic obstructive HCM.\n3.  Treatment Goals: The primary goal is to relieve the LVOT obstruction to alleviate symptoms and improve hemodynamics. The term \"definitive management\" typically refers to the intervention that anatomically corrects the problem with the best long-term outcomes.\n4.  Evaluating Options:\n    *   A. Surgical septal myectomy: This is the \"gold standard\" and definitive treatment for symptomatic, drug-refractory obstructive HCM. It effectively reduces the gradient and provides durable symptom relief. In patients who are surgical candidates (and a 65-year-old without stated comorbidities is generally considered one), this is the preferred option over ablation.\n    *   B. Alcohol septal ablation: This is an alternative to surgery, often reserved for patients who are poor surgical candidates (e.g., elderly, significant comorbidities) or who prefer a less invasive approach. While effective, it is not considered the gold standard compared to myectomy due to higher rates of repeat intervention and pacemaker requirements.\n    *   C. Implantable cardioverter-defibrillator (ICD) placement: While this patient has a high risk for sudden cardiac death (SCD) given the syncope, and an ICD might be indicated for SCD prevention, it does not treat the underlying LVOT obstruction or the associated exertional symptoms. The question asks for management in the context of obstruction and persistent symptoms.\n    *   D. Dual-chamber pacing: This can reduce the gradient in some patients but is generally reserved for those who are not candidates for septal reduction therapy (myectomy or ablation) or who need pacing for other reasons. It is less effective than septal reduction.\n    *   E. Verapamil initiation: While calcium channel blockers can be used if beta-blockers fail, they are still medical therapies. Since the patient has severe obstruction and syncope (a red flag), and has already failed first-line medical therapy, moving to definitive mechanical relief (SRT) is the standard of care rather than trialing another medication. Additionally, verapamil must be used with caution in severe obstruction due to vasodilatory effects.\n\nConclusion: Surgical septal myectomy is the most definitive management for relieving the obstruction and symptoms in this patient.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p04", "question_id": "ABMS20260101_grok-4-0709_p04-010", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "topics_mapped", "source_label_raw": "endocrinology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "source_question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed123.jsonl", "pred": "A", "model_outputs": "Based on the clinical presentation, the patient has developed Central Diabetes Insipidus (DI) following transsphenoidal surgery. This is a known complication where the posterior pituitary gland or the pituitary stalk is damaged, leading to a deficiency in antidiuretic hormone (ADH), also known as arginine vasopressin.\n\nThe diagnosis is supported by:\n1.  Polyuria: Urine output > 300 mL/hr (defined generally as > 3 L/24h or > 2.5-3 mL/kg/h).\n2.  Hypernatremia: Serum sodium of 148 mEq/L indicates a free water deficit.\n3.  Dilute Urine: Urine specific gravity of 1.002 indicates the kidneys are unable to concentrate urine despite the hypernatremia, confirming the lack of ADH effect.\n\nAnalysis of Options:\n*   A. Desmopressin acetate: This is a synthetic analogue of ADH. It is the drug of choice for central DI as it replaces the missing hormone, acts on renal V2 receptors to increase water reabsorption, decreases urine output, and helps normalize serum sodium levels.\n*   B. Hydrochlorothiazide: While used for nephrogenic DI (paradoxical effect), it is not the first-line treatment for acute central DI.\n*   C. Demeclocycline: This drug antagonizes ADH action and is used to treat Syndrome of Inappropriate Antidiuretic Hormone (SIADH). It would worsen DI.\n*   D. Tolvaptan: This is a vasopressin receptor antagonist used for treating hyponatremia (e.g., SIADH). It is contraindicated in patients with hypernatremia or DI.\n*   E. Conivaptan: Similar to tolvaptan, this is an ADH antagonist used for hyponatremia and is inappropriate for this patient.\n\nTherefore, the most appropriate initial pharmacologic intervention is ADH replacement with desmopressin.\n\nThe answer is (A)"}]